Mykare Health: Financial Breakdown
Decoding financial health metrics of Mykare Health
Total Revenue₹6.3 Cr50%Prev. FY
Total Expenses₹9.1 Cr29%Prev. FY
Profit After Tax₹-2.8 Cr0%Prev. FY
Total Assets₹10.9 Cr-16%Prev. FY
Net Profit Margin-43.9%34%Prev. FY
FAQs on Financials of Mykare Health
No. In FY25, Mykare Health reported a net loss of ₹2.8 Cr, so it was not profitable.
Mykare Health's revenue grew 50.5% year-on-year, from ₹4.2 Cr in FY24 to ₹6.3 Cr in FY25.
Mykare Health's estimated EBITDA for FY25 was ₹-2.7 Cr, derived from its profit before tax, finance costs, and depreciation & amortisation.
In FY25, Mykare Health posted revenue of ₹6.3 Cr (up 50.5% YoY) and a net loss of ₹2.8 Cr. Explore the full financials of Mykare Health here...
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links